These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11828946)

  • 1. Combination chemotherapy of carboplatin and gemcitabine against solid tumors: a phase I trial.
    Tassinari D; Drudi G; Panzini I; Pasini G; Arcangeli V; Fochessati F; Gianni L; Mianulli AM; Oliverio G; Pasquini E; Sartori S; Ravaioli A
    Int J Clin Oncol; 2001 Dec; 6(6):279-83. PubMed ID: 11828946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paclitaxel and carboplatin in combination with gemcitabine: a phase I-II trial in patients with advanced non-small-cell lung cancer. Gruppo Studio Tumori Polmonari Veneto (GSTPV).
    Favaretto A; Ceresoli GL; Paccagnella A; Barbieri F; Bearz A; Ghiotto C; Oniga F; Schiavon S; Frustaci S; Villa E
    Ann Oncol; 2000 Nov; 11(11):1421-6. PubMed ID: 11142482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study.
    Thomas P; Robinet G; Ferri-Dessens RM; Léna H; Gouva S; Vernejoux JM; Kleisbauer JP
    Lung Cancer; 2002 May; 36(2):191-8. PubMed ID: 11955654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I-II study of gemcitabine and carboplatin in stage IIIB-IV non-small-cell lung cancer.
    Iaffaioli RV; Tortoriello A; Facchini G; Caponigro F; Gentile M; Marzano N; Gravina A; Dimitri P; Costagliola G; Ferraro A; Ferrante G; De Marino V; Illiano A
    J Clin Oncol; 1999 Mar; 17(3):921-6. PubMed ID: 10071285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalating study of biweekly gemcitabine and carboplatin in patients with advanced cancer.
    Dudek AZ; Larson T; Keshtgarpour M; Kumar P
    Am J Clin Oncol; 2007 Oct; 30(5):481-6. PubMed ID: 17921707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer.
    Argiris A; Liptay M; LaCombe M; Marymont M; Kies MS; Sundaresan S; Masters G
    Lung Cancer; 2004 Aug; 45(2):243-53. PubMed ID: 15246197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I dose escalation study of biweekly gemcitabine and carboplatin in completely resected stage IB-IIIA nonsmall cell lung cancer.
    Tomizawa Y; Ishihara S; Iijima H; Imai H; Sato K; Yatomi M; Iwasaki Y; Yamada H; Kobayashi G; Ishida E; Inoue T; Aoki H; Watanabe S; Kawashima O; Mori M; Saito R
    Am J Clin Oncol; 2007 Oct; 30(5):498-502. PubMed ID: 17921710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I and pharmacokinetic study of gemcitabine administered at fixed-dose rate, combined with docetaxel/melphalan/carboplatin, with autologous hematopoietic progenitor-cell support, in patients with advanced refractory tumors.
    Nieto Y; Aldaz A; Rifón J; Pérez-Calvo J; Zafra A; Zufia L; Viúdez A; Viteri S; Aramendía JM; Aristu J; Centeno C; Moreno M; Sayar O; Hernández M
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1324-37. PubMed ID: 17950919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gemcitabine plus carboplatin combination therapy as second-line treatment in patients with relapsed breast cancer.
    Nasr FL; Chahine GY; Kattan JG; Farhat FS; Mokaddem WT; Tueni EA; Dagher JE; Ghosn MG
    Clin Breast Cancer; 2004 Jun; 5(2):117-22; discussion 123-4. PubMed ID: 15245614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study.
    Soo RA; Lim HL; Wang LZ; Lee HS; Millward MJ; Tok LT; Lee SC; Lehnert M; Goh BC
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):153-8. PubMed ID: 12750842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II study of gemcitabine and carboplatin in patients with advanced non-small-cell lung cancer.
    Wang LR; Huang MZ; Zhang GB; Xu N; Wu XH
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):601-7. PubMed ID: 17549479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors.
    Leijen S; van Geel RM; Pavlick AC; Tibes R; Rosen L; Razak AR; Lam R; Demuth T; Rose S; Lee MA; Freshwater T; Shumway S; Liang LW; Oza AM; Schellens JH; Shapiro GI
    J Clin Oncol; 2016 Dec; 34(36):4371-4380. PubMed ID: 27601554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.
    Gajra A; Mehdi SA; Kirshner J; Newman N; Graziano SL
    Lung Cancer; 2001 May; 32(2):189-96. PubMed ID: 11325490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study to evaluate multiple regimens of intravenous 5-fluorouracil administered in combination with weekly gemcitabine in patients with advanced solid tumors: a potential broadly active regimen for advanced solid tumor malignancies.
    Mani S; Vogelzang NJ; Bertucci D; Stadler WM; Schilsky RL; Ratain MJ
    Cancer; 2001 Sep; 92(6):1567-76. PubMed ID: 11745236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase Ib study of dovitinib in combination with gemcitabine plus cisplatin or gemcitabine plus carboplatin in patients with advanced solid tumors.
    Galsky MD; Posner M; Holcombe RF; Lee KM; Misiukiewicz K; Tsao CK; Godbold J; Soto R; Gimpel-Tetra K; Lowe N; Oh WK
    Cancer Chemother Pharmacol; 2014 Sep; 74(3):465-71. PubMed ID: 25023489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carboplatin and gemcitabine in the palliative treatment of stage IV non-small cell lung cancer: definitive results of a phase II trial.
    Tassinari D; Fochessati F; Arcangeli V; Sartori S; Agostini V; Fantini M; Genestreti G; Grassia S; Ioli G; Imola M; Iorio D; Mianulli AM; Monticelli G; Oliverio G; Panzini I; Papi M; Poggi B; Polselli A; Pulini S; Tamburini E; Fattori PP; Ravaioli A
    Tumori; 2004; 90(1):54-9. PubMed ID: 15143973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biweekly Carboplatin Plus Gemcitabine as First-Line Treatment of Elderly Patients With Advanced Squamous Non-Small-cell Lung Cancer: A Multicenter Phase I-II Trial by the Hellenic Oncology Research Group.
    Karampeazis A; Vamvakas L; Kentepozidis N; Polyzos A; Chandrinos V; Rigas G; Christofyllakis C; Kotsakis A; Hatzidaki D; Pallis AG; Georgoulias V
    Clin Lung Cancer; 2016 Nov; 17(6):543-549. PubMed ID: 27397849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I study of carboplatin in combination with gemcitabine and irinotecan in patients with solid tumors: preliminary evidence of activity in small cell and neuroendocrine carcinomas.
    de Lima Lopes G; Chiappori A; Simon G; Haura E; Sullivan D; Antonia S; Langevin M; Lush R; Rocha-Lima CM
    Cancer; 2007 Apr; 109(7):1413-9. PubMed ID: 17326096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose finding study for combination treatment with topotecan and gemcitabine of patients with recurrent ovarian cancer after failure of first-line chemotherapy with Paclitaxel and platinum.
    Sehouli J; Stengel D; Oskay G; Blohmer J; Kaubitzsch S; Lichtenegger W;
    Onkologie; 2004 Feb; 27(1):58-64. PubMed ID: 15007250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.
    Hainsworth JD; Burris HA; Erland JB; Morrissey LH; Meluch AA; Kalman LA; Hon JK; Scullin DC; Smith SW; Greco FA
    Cancer; 1999 Mar; 85(6):1269-76. PubMed ID: 10189131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.